Trading Analysis Report: CGNX
- Analysis date: 2026-06-01
- Processed decision: Buy
- Price Target: 78
I. Analyst Team Reports
Market Analyst
Market Report
Cognex Corporation (CGNX) traded at $65.85 on May 29, 2026. yfinance showed a 52-week range of $29.22-$71.90, a 50-day average of $56.90, and a 200-day average of $46.76.
The stock has already repriced sharply. The local yfinance history showed a 119.7% one-year return and 78.3% YTD return.
StockAnalysis placed CGNX in the AI stock universe. Cognex fits the queue because it is a machine-vision automation company with deep learning, AI vision systems, and OneVision software aimed at manufacturing inspection.
Market read: momentum is strong, but the setup is no longer cheap. Use Buy with a $78 target because Q1 execution and Q2 guidance support further upside, while valuation limits target aggressiveness.
Sentiment Analyst
Sentiment Report
Sentiment is constructive after Q1 2026 results and new AI vision announcements.
Cognex reported Q1 revenue of $268 million, up 24% year over year and 21% on a constant-currency basis. Operating margin was 22.3%, adjusted EBITDA margin was 26.9%, and adjusted diluted EPS was $0.34, up 113% year over year.
Management also highlighted the launch of two AI vision platforms: In-Sight 6900 powered by NVIDIA and In-Sight 3900 embedded AI vision system powered by Qualcomm.
The sentiment constraint is valuation. yfinance showed trailing P/E of 77.47x, forward P/E of 37.38x, and price/sales of 10.47x.
Sentiment read: Buy because operating momentum and AI product positioning are improving faster than expected, but position sizing should recognize premium valuation.
News Analyst
News Report
The main current news item is Cognex's Q1 2026 earnings release.
Revenue was $268 million, compared with $216 million in Q1 2025. Gross margin was 71.1% compared with 66.8% a year earlier. Operating income was $60 million, up 131% year over year. Net income per diluted share was $0.31, and adjusted diluted EPS was $0.34.
Free cash flow was $42 million in Q1, up 11% year over year. Cognex returned $113 million to shareholders during the quarter, primarily through $99 million of share repurchases and $14 million of dividends.
Q2 2026 guidance calls for revenue of $280-$300 million, adjusted EBITDA margin of 28%-31%, and adjusted EPS of $0.40-$0.44. The investor presentation said year-over-year growth should reflect broader factory automation end markets and logistics, while sequential growth should benefit from consumer electronics seasonality.
On May 13, 2026, Cognex announced general availability of OneVision, its collaborative AI vision development environment. More than 100 customers used OneVision since the June 2025 beta launch.
News read: CGNX has earnings momentum, AI product momentum, and a clear next-quarter guide that gives investors a concrete catalyst.
Fundamentals Analyst
Fundamentals Report
CGNX fundamentals show a high-quality but premium-valued automation business.
yfinance showed market cap of approximately $10.96 billion, enterprise value of approximately $10.74 billion, total revenue of approximately $1.05 billion, operating cash flow of approximately $250.1 million, free cash flow of approximately $181.4 million, total cash of approximately $296.8 million, and total debt of approximately $74.0 million.
The same snapshot showed gross margin of 68.0%, operating margin of 22.3%, profit margin of 13.6%, trailing P/E of 77.47x, forward P/E of 37.38x, price/sales of 10.47x, and a dividend yield field of 0.51.
The 2025 Form 10-K says Cognex is a global technology leader in industrial machine vision systems. It also says the company aims to be the leading provider of AI technology for industrial machine vision applications, with core markets including logistics, packaging, consumer electronics, and automotive.
Fundamental read: Buy is justified by high margins, net cash, growth recovery, and AI vision exposure, but the stock needs continued execution to defend its valuation.
II. Research Team Decision
Bull Researcher
Bull Research
The bull case is that Cognex is evolving from a cyclical machine-vision supplier into a higher-value AI vision platform company.
Q1 2026 revenue increased 24% year over year, adjusted EBITDA doubled to $72 million, and adjusted EBITDA margin expanded to 26.9%. Q2 guidance implies another strong quarter, with revenue of $280-$300 million and adjusted EBITDA margin of 28%-31%.
The AI product cycle is real. Cognex introduced the In-Sight 6900 powered by NVIDIA and the In-Sight 3900 embedded AI vision system powered by Qualcomm. OneVision's general availability adds a collaborative software layer for AI inspection deployment across manufacturing operations.
The balance sheet supports flexibility. yfinance showed total cash of about $296.8 million versus total debt of about $74.0 million, and Cognex returned $113 million to shareholders in Q1.
Bull conclusion: CGNX can work as a physical-AI and factory-automation compounder if AI vision adoption broadens across logistics, consumer electronics, automotive, and packaging.
Bear Researcher
Bear Research
The bear case is valuation, cyclicality, and execution risk.
The stock has already gained 119.7% over one year and 78.3% YTD in the local yfinance history. At 10.47x sales and 37.38x forward earnings, expectations already price in strong margin expansion and durable AI growth.
Cognex remains exposed to cyclical factory automation spending. Q2 guide commentary depends partly on consumer electronics seasonality and broader factory automation/logistics demand.
The 2025 Form 10-K flags risks around scaling the customer base, transforming the salesforce, managing costs, component supply, and acquisition/intangible impairment exposure. Those risks matter because the investment case depends on broadening AI vision adoption beyond pilot projects.
Bear conclusion: CGNX could derate quickly if Q2 guidance is not met, margins flatten, or AI vision deployments fail to scale into recurring demand.
Research Manager
Research Manager Synthesis
The bull case is strong Q1 execution, a credible Q2 guide, margin expansion, net cash, shareholder returns, and a timely AI vision product cycle.
The bear case is that the stock already reflects much of that improvement, with high price/sales and forward P/E multiples after a major rally.
The correct conclusion is Buy, but not an aggressive one. The $78 target is close to the yfinance mean target of $76.25 and median target of $75.50, with a modest premium for AI vision momentum.
Synthesis: assign Buy with a $78 target.
III. Trading Team Plan
Trader
Trader View
CGNX is trading above its $56.90 50-day average and $46.76 200-day average, and close to its $71.90 52-week high.
Upside trigger: Q2 revenue above $300 million, adjusted EPS above $0.44, adjusted EBITDA margin above 31%, stronger OneVision adoption, or evidence that NVIDIA- and Qualcomm-powered AI vision systems are expanding addressable demand.
Downside trigger: Q2 revenue below $280 million, adjusted EPS below $0.40, gross margin pressure, weak factory automation demand, consumer electronics softness, or slowing AI deployment momentum.
Trading plan: Buy with a $78 6-12 month base-case target, but reassess if the stock breaks below the 50-day average on weak volume-adjusted earnings revisions.
IV. Risk Management Team Decision
Aggressive Analyst
Aggressive Risk View
Aggressive investors can own CGNX for AI vision upside, operating leverage, and factory automation recovery.
The main risk is paying a premium multiple after a rapid rally.
Aggressive conclusion: Buy.
Conservative Analyst
Conservative Risk View
Conservative investors should be more selective because valuation is already high.
The balance sheet, margins, and cash generation are strong, but downside could be meaningful if growth normalizes.
Conservative conclusion: Hold for existing holders; Buy only on pullbacks.
Neutral Analyst
Neutral Risk View
The neutral view is constructive but valuation-aware.
Q1 results and Q2 guide support the stock, while the AI vision roadmap creates a differentiated growth story. However, the current multiple requires continued execution.
Neutral conclusion: Buy with disciplined target and risk controls.
V. Portfolio Manager Decision
Portfolio Manager
Portfolio Manager Decision
Rating: Buy Price Target: 78
Horizon: 6-12 months Current Price Reference: $65.85 on 2026-05-29
Cognex Corporation is rated Buy. CGNX is included in the web-researched AI queue because it is a machine-vision automation company using AI, deep learning, embedded vision systems, and collaborative AI vision software for industrial inspection.
Cognex reported Q1 2026 revenue of $268 million, up 24% year over year and 21% on a constant-currency basis. Operating margin was 22.3%, adjusted EBITDA was $72 million, adjusted EBITDA margin was 26.9%, net income per diluted share was $0.31, and adjusted diluted EPS was $0.34, up 113% year over year.
Gross margin improved to 71.1% from 66.8% a year earlier. Operating income rose to $60 million from $26 million in Q1 2025. Free cash flow was $42 million, up 11% year over year.
Cognex returned $113 million to shareholders during Q1, mainly through $99 million of share repurchases and $14 million of dividends. The board also declared a quarterly cash dividend of $0.085 per share payable June 4, 2026.
The Q2 2026 outlook calls for revenue of $280-$300 million, adjusted EBITDA margin of 28%-31%, and adjusted EPS of $0.40-$0.44. The investor presentation says year-over-year revenue growth should reflect broader factory automation end markets and logistics, while sequential growth should benefit from consumer electronics seasonality.
The AI product cycle is the key differentiator. In Q1, Cognex introduced the In-Sight 6900 powered by NVIDIA and the In-Sight 3900 embedded AI vision system powered by Qualcomm. On May 13, 2026, the company announced general availability of OneVision, a collaborative AI vision development environment designed to simplify and scale AI-powered inspection across manufacturing operations. More than 100 customers used OneVision since the June 2025 beta launch.
The 2025 Form 10-K says Cognex is a global technology leader in industrial machine vision systems. It also says the company aims to be the leading provider of AI technology for industrial machine vision applications. Core markets include logistics, packaging, consumer electronics, and automotive.
yfinance showed a latest price of $65.85, market cap of approximately $10.96 billion, enterprise value of approximately $10.74 billion, 52-week range of $29.22-$71.90, trailing P/E of 77.47x, forward P/E of 37.38x, price/sales of 10.47x, total revenue of approximately $1.05 billion, operating cash flow of approximately $250.1 million, free cash flow of approximately $181.4 million, total cash of approximately $296.8 million, total debt of approximately $74.0 million, and a dividend yield field of 0.51.
The main risks are premium valuation, factory automation cyclicality, consumer electronics seasonality, execution risk in salesforce transformation, customer-base expansion, cost reduction execution, component supply risk, and the need to convert AI vision product launches into durable customer adoption.
The $78 target is near the analyst target range visible in yfinance, with modest additional credit for Q1 outperformance, Q2 guidance, AI vision product launches, OneVision commercialization, and net-cash flexibility. Buy is appropriate, but the target remains disciplined because the stock already reflects a large recovery.